デフォルト表紙
市場調査レポート
商品コード
1717244

近視治療の世界市場レポート 2025年

Myopia Treatment Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
近視治療の世界市場レポート 2025年
出版日: 2025年04月29日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

近視治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.5%で281億6,000万米ドルに成長します。予測期間に予測される成長は、遠方視力障害の有病率の上昇、デジタルプラットフォームの利用の増加、ヘルスケアインフラの拡大、近視の罹患率の増加、視力喪失症例の増加に起因しています。この期間に予測される主な動向には、硬質ガス透過性コンタクトレンズの採用、光ベースの治療法の進歩、遺伝的要因の革新的研究、デジタルプラットフォームとアプリケーションの統合、アトロピン点眼製剤の開発などがあります。

近視治療市場の成長は、スクリーンタイムの増加によって牽引されると予測されます。スクリーンタイムとは、スマートフォン、タブレット、コンピュータ、テレビなどのスクリーンを備えた機器を使用する時間のことです。この増加の要因には、ストリーミング・サービス、ソーシャル・メディア・プラットフォーム、リモート・ワーク、バーチャル・ミーティングの人気の高まりが含まれます。近視治療は、長時間の画面使用による眼精疲労や不快感を和らげ、視覚の明瞭さ、集中力、全体的な快適さを高めるのに有益です。例えば、2024年10月、米国の政府機関である疾病対策予防センター(CDC)のデータによると、2021年7月から2023年12月までの間に、12~17歳の10代の50.4%が毎日4時間以上スクリーンに向かっていると回答したことが明らかになりました。さらに、22.8%が3時間、17.8%が2時間、6.1%が1時間、3.0%が1日1時間未満をスクリーンに費やしています。このようなスクリーン利用時間の動向が、近視治療市場の拡大を後押しする重要な要因となっています。

近視治療市場の主要企業は、診断精度の向上と個別化治療の提供を目指し、光学式バイオメーターなどの革新的製品の開発に注力しています。光学バイオメーターは、光を利用して軸長や角膜曲率などの眼球パラメータを評価し、眼疾患の診断やモニタリングに役立ちます。例えば、2023年2月、日本の眼科製品専門会社である日本電産株式会社は、AL-Scan MとMV-1装置を発表しました。AL-Scan Mは、3Dオートトラッキングとオートショット機能を備えており、オートレフラクターと同様の効率的でユーザーフレンドリーな測定が可能です。これらの機能強化により、特に若年層の患者さんのスループットが向上します。AL-Scan Mは、近視の進行を追跡するのに不可欠な正確な軸長測定用に設計されています。さらに、MV-1 Myopia Viewerソフトウェアとスムーズに統合できるため、治療履歴や患者の行動の追跡が容易になります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界近視治療PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の近視治療市場:成長率分析
  • 世界の近視治療市場の実績:規模と成長, 2019-2024
  • 世界の近視治療市場の予測:規模と成長, 2024-2029, 2034F
  • 世界近視治療総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の近視治療市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 単純近視
  • 強度近視
  • 病的近視
  • 世界の近視治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 眼鏡
  • コンタクトレンズ
  • 屈折矯正手術
  • レーザー支援による上皮内角膜腫れ症(LASIK)
  • 屈折矯正角膜切除術(PRK)
  • オルソケラトロジー(オルソK)
  • 世界の近視治療市場:投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • オーラル
  • 非経口
  • その他の投与経路
  • 世界の近視治療市場:流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 直接入札
  • 小売売上高
  • その他の流通チャネル
  • 世界の近視治療市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院または臨床検査室
  • 医師の診療所
  • リファレンスラボ
  • その他のエンドユーザー
  • 世界の近視治療市場単純近視の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 軽度近視
  • 中等度近視
  • 世界の近視治療市場強度近視の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 重度の近視
  • 高度近視
  • 世界の近視治療市場病的近視の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 変性近視
  • 悪性近視

第7章 地域別・国別分析

  • 世界の近視治療市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の近視治療市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 近視治療市場:競合情勢
  • 近視治療市場:企業プロファイル
    • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Hoya Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Vision Care Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • CooperVision Inc.
  • Menicon Co. Ltd.
  • Topcon Healthcare Inc.
  • Essilor Ltd.
  • NIDEK CO. LTD.
  • SightGlass Vision Inc.
  • SCHWIND eye-tech-solutions GmbH
  • Visioneering Technologies Inc.
  • MEDMONT INTERNATIONAL PTY LTD.
  • Vyluma Inc.
  • Haag-Streit Holding AG
  • NovaSight Ltd.
  • Euclid Vision Corporation
  • Treehouse Eyes LLC
  • Sydnexis Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 近視治療市場2029:新たな機会を提供する国
  • 近視治療市場2029:新たな機会を提供するセグメント
  • 近視治療市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33822

Myopia treatment involves medical or corrective methods designed to address or manage myopia, commonly known as nearsightedness. This refractive error causes distant objects to appear blurry while nearby objects remain clear. The primary aim of myopia treatment is to enhance vision and improve quality of life by correcting refractive errors. Additionally, it focuses on controlling the progression of myopia, thereby reducing long-term dependence on corrective lenses for better vision health.

The primary categories of myopia treated include simple myopia, high myopia, and pathological myopia. Simple myopia, caused by an elongated eyeball or an overly curved cornea, results in blurry distant vision and can be treated with corrective lenses or refractive surgery. Treatment options include eyeglasses, contact lenses, refractive surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and orthokeratology (Ortho-K). These treatments are administered through various methods, such as oral or parenteral routes, among others. Distribution channels include direct tender and retail sales, catering to end users such as hospitals, clinical laboratories, physician offices, and reference laboratories.

The myopia treatment market research report is one of a series of new reports from The Business Research Company that provides myopia treatment market statistics, including the myopia treatment industry global market size, regional shares, competitors with the myopia treatment market share, detailed myopia treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the myopia treatment industry. This myopia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The myopia treatment market size has grown strongly in recent years. It will grow from $17.82 billion in 2024 to $19.58 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth observed during the historical period can be attributed to factors such as a growing geriatric population, heightened government awareness initiatives, increased public awareness about myopia treatment, greater investment in research and development, and a rising prevalence of distance vision impairment.

The myopia treatment market size is expected to see strong growth in the next few years. It will grow to $28.16 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth projected for the forecast period can be attributed to the rising prevalence of distance vision impairment, increased utilization of digital platforms, expanding healthcare infrastructure, a growing incidence of myopia, and an increase in cases of vision loss. Key trends anticipated during this period include the adoption of rigid gas-permeable contact lenses, advancements in light-based therapies, innovative research into genetic factors, the integration of digital platforms and applications, and developments in atropine eye drop formulations.

The growth of the myopia treatment market is anticipated to be driven by the rising levels of screen time. Screen time refers to the duration individuals spend using devices equipped with screens, such as smartphones, tablets, computers, and televisions. Factors contributing to this increase include the growing popularity of streaming services, social media platforms, remote work, and virtual meetings. Myopia treatments are beneficial in mitigating eye strain and discomfort caused by extended screen use, enhancing visual clarity, focus, and overall comfort. For example, in October 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based government agency, revealed that between July 2021 and December 2023, 50.4% of teenagers aged 12-17 reported spending four or more hours daily on screens. Additionally, 22.8% spent three hours, 17.8% spent two hours, 6.1% spent one hour, and 3.0% spent less than one hour per day on screens. This growing screen time trend is a significant factor fueling the expansion of the myopia treatment market.

Leading companies in the myopia treatment market are concentrating on developing innovative products, such as optical biometers, to improve diagnostic accuracy and provide personalized treatments. Optical biometers utilize light to assess eye parameters such as axial length and corneal curvature, aiding in the diagnosis and monitoring of eye conditions. For example, in February 2023, NIDEK Co., Ltd., a Japanese company specializing in ophthalmic products, introduced the AL-Scan M and MV-1 devices. The AL-Scan M features 3D auto-tracking and auto-shot capabilities, allowing for efficient and user-friendly measurements similar to those of an autorefractor. These enhancements boost patient throughput, especially for younger patients. The AL-Scan M is designed for precise axial length measurements, which are vital for tracking myopia progression. Additionally, it integrates smoothly with the MV-1 Myopia Viewer software, facilitating the tracking of treatment history and patient behavior.

In January 2023, CooperVision, Inc., a US-based producer of soft contact lenses, acquired SynergEyes, Inc. for an undisclosed sum. This acquisition is intended to bolster CooperVision's specialty contact lens portfolio and reinforce its standing in the advanced ocular care market. SynergEyes, Inc., also based in the US, specializes in manufacturing contact lenses designed to address myopia progression.

Major players in the myopia treatment market are Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd.

Asia Pacific was the largest region in the myopia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in myopia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the myopia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myopia treatment market consists of revenues earned by entities by providing services such as myopia control programs, vision therapy, and lifestyle and behavioral guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The myopia treatment market includes sales of prescription glasses, atropine drops, and myopia control glasses. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myopia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myopia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myopia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The myopia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Simple Myopia; High Myopia; Pathological Myopia
  • 2) By Treatment: Eyeglasses; Contact Lenses; Refractive Surgery; Laser-Assisted In Situ Keratomileusis (LASIK); Photorefractive Keratectomy (PRK); Orthokeratology (Ortho-K)
  • 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
  • 4) By Distribution Channel: Direct Tender; Retail Sales; Other Distribution Channels
  • 5) By End-User: Hospital Or Clinical Laboratories; Physician Offices; Reference Laboratories; Other End-Users
  • Subsegments:
  • 1) By Simple Myopia: Mild Myopia; Moderate Myopia
  • 2) By High Myopia: Severe Myopia; Very Severe Myopia
  • 3) By Pathological Myopia: Degenerative Myopia; Malignant Myopia
  • Companies Mentioned:Regeneron Pharmaceuticals Inc.; Alcon Inc.; Bausch Health Companies Inc.; Hoya Corporation; Johnson & Johnson Vision Care Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Myopia Treatment Market Characteristics

3. Myopia Treatment Market Trends And Strategies

4. Myopia Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Myopia Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Myopia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Myopia Treatment Market Growth Rate Analysis
  • 5.4. Global Myopia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Myopia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Myopia Treatment Total Addressable Market (TAM)

6. Myopia Treatment Market Segmentation

  • 6.1. Global Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simple Myopia
  • High Myopia
  • Pathological Myopia
  • 6.2. Global Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Eyeglasses
  • Contact Lenses
  • Refractive Surgery
  • Laser-Assisted In Situ Keratomileusis (LASIK)
  • Photorefractive Keratectomy (PRK)
  • Orthokeratology (Ortho-K)
  • 6.3. Global Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administration
  • 6.4. Global Myopia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Tender
  • Retail Sales
  • Other Distribution Channels
  • 6.5. Global Myopia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Or Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Other End-Users
  • 6.6. Global Myopia Treatment Market, Sub-Segmentation Of Simple Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mild Myopia
  • Moderate Myopia
  • 6.7. Global Myopia Treatment Market, Sub-Segmentation Of High Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Severe Myopia
  • Very Severe Myopia
  • 6.8. Global Myopia Treatment Market, Sub-Segmentation Of Pathological Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Degenerative Myopia
  • Malignant Myopia

7. Myopia Treatment Market Regional And Country Analysis

  • 7.1. Global Myopia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Myopia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Myopia Treatment Market

  • 8.1. Asia-Pacific Myopia Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Myopia Treatment Market

  • 9.1. China Myopia Treatment Market Overview
  • 9.2. China Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Myopia Treatment Market

  • 10.1. India Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Myopia Treatment Market

  • 11.1. Japan Myopia Treatment Market Overview
  • 11.2. Japan Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Myopia Treatment Market

  • 12.1. Australia Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Myopia Treatment Market

  • 13.1. Indonesia Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Myopia Treatment Market

  • 14.1. South Korea Myopia Treatment Market Overview
  • 14.2. South Korea Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Myopia Treatment Market

  • 15.1. Western Europe Myopia Treatment Market Overview
  • 15.2. Western Europe Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Myopia Treatment Market

  • 16.1. UK Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Myopia Treatment Market

  • 17.1. Germany Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Myopia Treatment Market

  • 18.1. France Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Myopia Treatment Market

  • 19.1. Italy Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Myopia Treatment Market

  • 20.1. Spain Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Myopia Treatment Market

  • 21.1. Eastern Europe Myopia Treatment Market Overview
  • 21.2. Eastern Europe Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Myopia Treatment Market

  • 22.1. Russia Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Myopia Treatment Market

  • 23.1. North America Myopia Treatment Market Overview
  • 23.2. North America Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Myopia Treatment Market

  • 24.1. USA Myopia Treatment Market Overview
  • 24.2. USA Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Myopia Treatment Market

  • 25.1. Canada Myopia Treatment Market Overview
  • 25.2. Canada Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Myopia Treatment Market

  • 26.1. South America Myopia Treatment Market Overview
  • 26.2. South America Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Myopia Treatment Market

  • 27.1. Brazil Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Myopia Treatment Market

  • 28.1. Middle East Myopia Treatment Market Overview
  • 28.2. Middle East Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Myopia Treatment Market

  • 29.1. Africa Myopia Treatment Market Overview
  • 29.2. Africa Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Myopia Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Myopia Treatment Market Competitive Landscape
  • 30.2. Myopia Treatment Market Company Profiles
    • 30.2.1. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hoya Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Johnson & Johnson Vision Care Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Myopia Treatment Market Other Major And Innovative Companies

  • 31.1. CooperVision Inc.
  • 31.2. Menicon Co. Ltd.
  • 31.3. Topcon Healthcare Inc.
  • 31.4. Essilor Ltd.
  • 31.5. NIDEK CO. LTD.
  • 31.6. SightGlass Vision Inc.
  • 31.7. SCHWIND eye-tech-solutions GmbH
  • 31.8. Visioneering Technologies Inc.
  • 31.9. MEDMONT INTERNATIONAL PTY LTD.
  • 31.10. Vyluma Inc.
  • 31.11. Haag-Streit Holding AG
  • 31.12. NovaSight Ltd.
  • 31.13. Euclid Vision Corporation
  • 31.14. Treehouse Eyes LLC
  • 31.15. Sydnexis Inc.

32. Global Myopia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Myopia Treatment Market

34. Recent Developments In The Myopia Treatment Market

35. Myopia Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Myopia Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Myopia Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Myopia Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer